Integrating advance research directives into the European Legal Framework

European Journal of Health Law

Volumn 23, Issue 2, 2016, Pages 158-173

  Andorno, Roberto ^a,b   Gennet, Eloïse ^b,c   Jongsma, Karin ^d   Elger, Bernice ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c AIX MARSEILLE UNIVERSITY   (France)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Advance directives; Clinical trials; Consent; Council of Europe; Dementia research; European Union

Indexed keywords

CLINICAL TRIAL (TOPIC); DEMENTIA; EUROPEAN UNION; HUMAN; INFORMED CONSENT; LEGISLATION AND JURISPRUDENCE; LIVING WILL; RESEARCH SUBJECT;

ADVANCE DIRECTIVES; CLINICAL TRIALS AS TOPIC; DEMENTIA; EUROPEAN UNION; HUMANS; INFORMED CONSENT; RESEARCH SUBJECTS;

EID: 84975226337     PISSN: 09290273     EISSN: 15718093     Source Type: Journal    
DOI: 10.1163/15718093-12341380     Document Type: Article

References (47)

1. See R. Andorno, N. Biller-Andorno and S. Brauer, 'Advance Health Care Directives. Towards a Coordinated European Policy?', European Journal of Health Law 16(3) (2009) 207-227
2. S. Negri (ed.), Self-Determination, Dignity, and End-of-Life Care. Regulating Advance Directives in National and International Law (Leiden: Brill Academic Publishers, 2012)
3. T. Goffin, 'Advance Directives as an Instrument in an Ageing Europe', European Journal of Health Law 19(2) (2012) 121-140
4. D. Veshi and G. Neitzke, 'Advance Directives in Some Western European Countries: A Legal and Ethical Comparison between Spain, France, England, and Germany', European Journal of Health Law 22(4) (2015) 321-345.
5. See S. Lötjönen, 'Medical research on patients with dementia: the role of advance directives in European legal instruments', European Journal of Health Law 13(3) (2006) 235-261
6. R. Pierce, 'A changing landscape for advance directives in dementia research', Social Sciences and Medicine 70 (2010) 623-630
7. H. Helmchen, 'Ethics of clinical research with mentally ill persons', European Archives of Psychiatry and Clinical Neuroscience 262 (2012) 441-452
8. K. Jongsma and S. van de Vathorst, 'Advance directives in dementia research: The opinions and arguments of clinical researchers - an empirical study', Research Ethics (2014), published online 8 August 2014: doi: 10.1177/1747016114523422.
9. Alzheimer Europe, Position paper on the use of advance directives (2009), para. 31, online at www.alzheimer-europe.org/Policy-in-Practice2/Our-opinion-on/Advance-directives, retrieved 14 July 2015.
10. C.B. Stocking, G.W. Hougham, D.D. Danner, M.B. Patterson, P.J. Whitehouse and G.A. Sachs, 'Speaking of research advance directives: planning for future research participation', Neurology 66(9) (2006) 1361-1366.
11. Alzheimer's Disease International, World Alzheimer Report 2014, Dementia and Risk Reduction: An Analysis of Protective and Modifiable Factors. Retrieved 14 July 2015, www.alz.co.uk/research/world-report-2014.
12. S. Yudofsky and R. Hales (eds.), The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences (Washington, DC: Psychiatric Publishing, 2008), p. 452.
13. E. Abdoler and D. Wendler, 'Using data to improve surrogate consent for clinical research with incapacitated adults', Journal of Empirical Research on Human Research Ethics 7(2)(2012) 37-50.
14. See for instance R. Dresser, 'Dworkin on Dementia: Elegant Theory, Questionable Policy', Hastings Center Report 25(6) (1995) 32-38.
15. R. Levine, Ethics and Regulation of Clinical Research (Baltimore, MD: Urban and Schwarzenberg, 1986), pp. 270-274
16. National Institutes of Health, Consent Process in Research Involving Impaired Human Subjects (1987), Clinical Center Policy and Communications Bulletin, n 87-4
17. National Bioethics Advisory Commission (NBAC), Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity, Report and Recommendations, vol. I (Washington, DC: US Government Printing Office, 1998), chapter 3.
18. A. Moorehouse and D. Weisstub, 'Advance directives for research: ethical problems and responses', International Journal of Law and Psychiatry 19(2) (1996) 107-141, at 107
19. P. Backlar, 'Anticipatory planning for research participants with psychotic disorders like Schizophrenia', Psychology, Public Policy, and Law 4(3) (1998) 829-853.
20. Canadian Institutes of Health Research, National Science and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, December 2014, Articles 3.10 and 3.11. Retrieved 14 July 2015, www.pre.ethics.gc.ca/pdf/eng/tcps2/TCPS-2-FINAL-Web.pdf.
21. Article 17, Council of Europe, Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine, Oviedo, 4. IV. 1997, ETS 164 [hereinafter Biomedicine Convention].
22. Article 31, Council Regulation 536/2014 on Clinical Trials on Medicinal Products for Human Use, and Repealing Directive 2001/20/EC, 2014 OJ (L 158) 1 [hereinafter EU Regulation on Clinical Trials].
23. Council Directive 2001/20 on the Approximation of the Law, Regulations and Administrative Provisions of the Member States relating to the Implementation of Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use, OJ L 121/34 (2001) [hereinafter 2001 Directive].
24. Biomedicine Convention, Article 9.
25. Council of Europe, Explanatory Report to the Additional Protocol to the Convention on Human Rights and Biomedicine, Concerning Biomedical Research, Strasbourg, 25 I. 2005, ETS 195 [hereinafter Explanatory Report to the Additional Protocol, 2005], para. 62.
26. Mental Capacity Act 2005, s 33(2).
27. EU Commission. Proposal for a Regulation of the European Parliament and of the Council on Clinical Trials on Medicine Products for Human Use, and Rrepealing Directive 2001/20/EC. Brussels, 17 July 2012, p. 2, http://ec.europa.eu/health/files/clinicaltrials/2012-07/proposal/2012-07-proposal-en.pdf, retrieved 14 July 2015.
28. Alzheimer Europe, 'The Ethics of Dementia Research' (2011), chapter 4, www.alzheimer-europe.org/Ethics/Ethical-issues-in-practice/Ethics-of-dementia-research. retrieved 14 July 2015.
29. R. Dresser, 'Advance directives in dementia research. Promoting Autonomy and Protecting Subjects', IRB. Ethics & Human Research 23(1) (2001) 1-6 at 4.
30. M. Trachsel, H. Hermann, and N. Biller-Andorno, 'Cognitive Fluctuations as a Challenge for the Assessment of Decision-Making Capacity in Patients with Dementia', American Journal of Alzheimer's Disease and Other Dementias 30(4) (2015) 360-363.
31. World Medical Association, Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects (2013), para. 26.
32. Regarding the importance of the specificity of the consent, see S. Gevers, 'Dementia and the Law', European Journal of Health Law 13(3) (2006) 209-217, at 217.
33. K. Jongsma and S. van de Vathorst, 'Dementia research and advance consent: it is not about critical interest', Journal of Medical Ethics (2014) (published online 19 September 2014; doi:10.1136/medethics-2014-102445).
34. See Council of Europe, Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research, 25. I. 2005 [hereinafter Additional Protocol on Biomedical Research], Article 24.2.
35. Biomedicine Convention Article 17.1.v; Additional Protocol on Biomedical Research, Article 15 1.v.
36. EU Regulation on Clinical Trials, Article 31.
37. T. Lemmens, 'End-of-life decisions and demented patients. What to do if patient's current and past wishes are in conflict with each other?', European Journal of Health Law 19(2) (2012) 177-186.
38. Biomedicine Convention, Articles 6.3 and 17.iv; EU Regulation on Clinical Trials, Article 31.1.a.
39. See T. Buller, 'Advance consent, critical interests and dementia research', Journal of Medical Ethics (2014) published online 12 August 2014, doi: 10.1136/medethics-2014-102024)
40. Biomedicine Convention, Article 17
41. Additional Protocol on Biomedical Research, Article 15
42. EU Regulation on Clinical Trials, Article 31.
43. Biomedicine Convention, Article 26.
44. American College of Physicians (ACP), 'Cognitively Impaired Subjects. Position Paper', Annals of Internal Medicine 111(10) (1989) 843
45. P. Muthappan, H. Foster, and D. Wendler, 'Research advance directives: protection or obstacle?', American Journal of Psychiatry 162(12) (2005) 2389-2391.
46. See Council of Europe's Steering Committee on Bioethics, Guide for Research Ethics Committee Members, (Strasbourg: Council of Europe, 2012). Retrieved 14 July 2015, www.coe.int/t/dg3/healthbioethic/activities/02-biomedical-research-en/guide/Guide-EN.pdf.
47. See European Commission, Clinical Trials. General Information. Retrieved 14 July 2015, http://ec.europa.eu/health/human-use/clinical-trials/information/index-en.htm#ct4.